US company claims to have 90%of human genome on its databaseBMJ 2000; 320 doi: https://doi.org/10.1136/bmj.320.7229.206 (Published 22 January 2000) Cite this as: BMJ 2000;320:206
- Deborah Josefson
- San Francisco
The US biotechnology company Celera Genomics has announced that it has the DNA sequence of 90%of the human genome in its databases, far outpacing both its own schedule and that of the publicly funded human genome project, which was established in 1990.
Celera, founded in May 1998 by Craig Venter, claims to have sequenced 81%of the genome on its own. It has inferred an additional 9%from the publicly available data published by the National Institutes of Health in Maryland and by the Sanger Centre in Cambridge, England.
The company estimates that 97%of all human genes are already represented in its database, given a genome size of about 80000 genes.
Celera, which began its sequencing project on 8 …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial